mTORC1, a central metabolic regulator, demonstrates classic antagonistic pleiotropy in female reproduction. While physiological mTORC1 activation supports endometrial development and healthy cell turnover during younger years, sustained activation from aging or metabolic dysfunction triggers cellular senescence, oxidative stress, and impaired fertility. The pathway's dysfunction involves suppressed autophagy, DNA damage accumulation, and inflammatory SASP factors that compromise endometrial receptivity for embryo implantation. This finding illuminates why reproductive success declines with maternal age beyond simple egg quality issues. The endometrium itself becomes increasingly hostile to implantation through mTORC1-mediated senescence cascades. For longevity researchers, this represents a textbook example of evolutionary trade-offs where early-life reproductive advantages create later-life dysfunction. The clinical implications are substantial—monitoring mTORC1 activity could guide fertility treatments, particularly for older women or those with metabolic disorders like insulin resistance. More broadly, this suggests that interventions targeting mTORC1 and related pathways (AMPK activation, autophagy enhancement) might extend both reproductive lifespan and general healthspan, though the delicate balance required for reproductive success demands careful therapeutic approaches.